English
SpanishTrusted Resources: Evidence & Education
Scientific literature and patient education texts
A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients With Minimally Active Graves’ Ophthalmopathy
source: The Journal of Clinical Endocrinology and Metabolism
year: 2005
authors: Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J
summary/abstract:Context:
Radioiodine is an effective and safe treatment for hyperthyroidism but has been implicated as a risk factor for deterioration or new presentation of Graves’ ophthalmopathy (GO). Prophylactic glucocorticoids appear to prevent this effect.
Objective:
The objective of this study was to document the course of GO after radioiodine therapy.
Design:
This was a prospective observational study. Patients were assessed at baseline and 2, 4, 6, and 12 months after radioiodine therapy.
Setting:
The study was conducted at a tertiary referral center.
Patients:
Seventy-two GO patients with minimally active eye disease participated in the study.
Intervention:
A fixed dose of radioiodine was administered. T(4) was commenced 2 wk later to prevent hypothyroidism.
Main Outcome Measures:
Change in activity and severity of GO were analyzed.
Results:
Exophthalmometer readings, the width of the palpebral aperture, diplopia scores, and the clinical activity score improved significantly. By clinically significant criteria, the eye disease improved in four patients (transiently in three of the four cases), most likely attributable to the natural course of the disease. No patient’s eyes deteriorated.
Conclusions:
Radioiodine is not associated with deterioration of GO in patients with minimally active eye disease when postradioiodine hypothyroidism is prevented.
DOI: 10.1210/jc.2005-0507
read more full text
myBinderRelated Content
-
Relation between Therapy Options for Graves’ Disease and the Course of Graves’ Ophthalmopathy: A Systema...Background: The relation between therap...
-
FDA Approves First Treatment for Thyroid Eye Disease (Teprotumumab)The U.S. Food and Drug Administration (F...
-
How to Prepare for an Appointment With a TED Specialisthttps://www.youtube.com/watch?v=sKQo63E2...
-
Reversible Pulmonary Hypertension and Clinical Right Heart Failure Associated With Graves’ DiseaseBackground: Heart failure is typically ...
-
Teprotumumab Improves Short and Long-Term Clinical Outcomes in Thyroid Eye DiseaseMost adults with thyroid eye disease rec...
-
Treatment Options for Thyroid Eye or Graves’ Disease at Ohio Statehttps://www.youtube.com/watch?v=2vcbs9hu...
-
Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee AnnouncementThe committee will discuss biologics lic...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
